Genenta Science SpA Sponsored ADR ( (GNTA) ) just unveiled an announcement.
Genenta Science S.p.A. and AGC Biologics S.p.A. have amended their Development and Master Services Agreement. The amendment introduces an Exclusive GMP Suite dedicated to Genenta’s cell therapy manufacturing, ensuring compliance with cGMP standards. This strategic move aims to enhance Genenta’s production capabilities, potentially improving efficiency and reliability in their manufacturing processes.
More about Genenta Science SpA Sponsored ADR
YTD Price Performance: -1.41%
Average Trading Volume: 13,930
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $89.25M
For detailed information about GNTA stock, go to TipRanks’ Stock Analysis page.